| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6185141 | Gynecologic Oncology | 2014 | 5 Pages |
Abstract
Ixabepilone as a single agent is not an active second-line therapy for uterine leiomyosarcoma previously treated with a taxane.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Linda R. Duska, John A. Blessing, Jacob Rotmensch, Robert S. Mannel, Parviz Hanjani, Peter G. Rose, Don S. Dizon,